Compound Profile
Phosphatidylserine
Phosphatidylserine carries a Grade B rating — moderate evidence.
Use extra caution — Generally safe Details
- Evidence
- Moderate evidence
- Typical onset
- Varies by prep
- Safety rating
- Use extra caution: Generally well tolerated
- Best for
- Cognitive Support, Cortisol Reduction, Neuroprotective
- Avoid / review if
- Anticoagulants (Theoretical)
Bottom line
- Evidence confidence
- Limited–moderate — older cognition trials plus some cortisol data
- Expected onset
- Weeks
- Give it
- 6–12 weeks
Safety: Generally well tolerated; discuss with a clinician if you take blood thinners.
On the evidence: Some cognition and cortisol trials, several older and small; soy-derived differs from earlier bovine sources.
Best for
- Stress-related cortisol
- Cognitive support with aging
- Exercise-stress recovery
Not ideal for
- Acute anxiety
- Same-day focus
- Young, healthy users expecting large gains
Consider instead: Ashwagandha — for the best-studied cortisol/stress option
How strong is the evidence?Limited–moderate
Why not higher
- Much of the strongest data is older and used different source material
- Modern soy-derived trials are smaller
- Effects are modest
Why not lower
- Multiple trials support memory and stress-cortisol benefits
- A clear role in cell-membrane and neuronal function
Practical takeaway: A reasonable, low-risk trial for stress-cortisol or age-related cognition over 6–12 weeks. Not a fast focus tool.
Safety
Safety & Cautions
Generally safe
Elevated caution
Caution level: Elevated. One caution category applies — read it before use.
- Hormonal Activity ContextHormone-adjacent wording is present and should be interpreted carefully.
Evidence-based safety
Caution when combined
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
High-Priority Caution
147 flagged pairingsBleeding / anticoagulant risk
High-Priority Caution
147 flagged pairingsBleeding / anticoagulant risk
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Data provenance recorded for 147 of 147 pairings in this mechanism group.
- aescin — Theoretical interaction certainty
- Aged Garlic Extract — Theoretical interaction certainty
- ajoene — Theoretical interaction certainty
- Ajwain — Theoretical interaction certainty
- Allicin — Theoretical interaction certainty
- Garlic — Theoretical interaction certainty
- American Ginseng Extract — Theoretical interaction certainty
- Andrographis — Theoretical interaction certainty
- Angelica Archangelica — Theoretical interaction certainty
- Angelica Dahurica — Theoretical interaction certainty
- Angelica Pubescens — Theoretical interaction certainty
- Angelica Root — Theoretical interaction certainty
+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence Summary
Profile-wide ·B ModerateEvidence lens
Useful signal, but study design, dose, and population still matter.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Cellular Protection · Hormonal Signaling Context · Stress Response Modulation
Research maturity: Established research — main contexts: Cognitive Support · Cortisol Reduction · Neuroprotective
Safety boundary: Safety note available — Generally safe
This profile cites 4 human studies.
Confidence estimate based on the design quality and consistency of published clinical trials.
Phosphatidylserine has a moderate evidence rating.
Grade B: Moderate Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Systematic review
- Risk of Bias
- Low
- Consistency
- Consistent
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (3)3 human evidence sources · 2 human trials · Participant totals not consistently reported · Consistency not yet classifiable
Filter by study class
Showing 3 of 3 studies.
What the evidence actually shows
This table contains 3 structured sources, including 3 human evidence sources; 2 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | A recent review covering phosphatidylserine and citicoline includes controlled ADHD and adult studies, but ingredient, age, formulation, and outcome differences prevent a single pooled nootropic conclusion. | PubMed → |
Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | A randomized placebo-controlled study in chronically stressed men found that a soy-based phosphatidylserine/phosphatidic-acid complex altered hypothalamic-pituitary-adrenal-axis stress reactivity. | PubMed → |
Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | Systematic evidence for phosphatidylserine is limited and concentrated in age-related cognitive complaints rather than healthy young adults. Selected cognitive signals should remain population- and formulation-specific. | PubMed → |
How Phosphatidylserine Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Phosphatidylserine Works
Dosing
- Dose guidance
- 100 300 mg/day
Mechanisms & biological pathways
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
- Cellular Protection
- Hormonal Signaling Context
- Stress Response Modulation
- Neuroprotective Activity
- Lipid Metabolism
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Review available sources for Phosphatidylserine
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Phosphatidylserine evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.